Early Data With Olaratumab in Soft Tissue Sarcoma
3 Views
administrator
07/18/23
The panelists, Brian Van Tine, MD, PhD; Shreyaskumar Patel, MD; Robin L. Jones, MD, MRCP; Jonathan Trent, MD, PhD; and Andrew Wagner, MD; discuss phase I/II data with olaratumab and its mechanism of action.
-
Category
Show more
Facebook Comments
No comments found